Prion

A prion (an acronym for proteinaceous infectious particle) is an infectious agent composed of a misfolded, self-templating protein isoform that lacks any informational nucleic acid (DNA or RNA). Formulated in 1982 by the American neurologist and biochemist Stanley B. Prusiner—who received the 1997 Nobel Prize in Physiology or Medicine—the prion paradigm resolved decades of biophysical anomalies surrounding the etiology of scrapie in sheep and transmissible spongiform encephalopathies (TSEs) in humans. While the central dogma of molecular biology states that biological sequence information flows unidirectionally from nucleic acids to polypeptides, prions demonstrate that epigenetic conformational information can be inherited and transmitted horizontally from polypeptide to polypeptide via template-directed protein folding.

In mammals, all known prion diseases arise from the structural conversion of a benign, host-encoded glycoprotein—the cellular prion protein (PrP^C)—into an insoluble, protease-resistant, β-sheet-rich conformer termed the scrapie isoform (PrP^Sc). Accumulation of PrP^Sc oligomers and amyloid fibrils within the central nervous system triggers progressive synaptic loss, astrocytic gliosis, intraneuronal vacuolation ("spongiform" change), and universal lethality across sporadic, genetic, and infectious clinical manifestations.

The Host PRNP Gene and Native PrP^C Conformation

In humans, the precursor to the prion protein is encoded by the single-copy gene PRNP located on the short arm of chromosome 20 (20p13). The entire 253-amino-acid open reading frame resides within a single exon, precluding alternative splicing variations. Following endoplasmic reticulum translocation, cleavage of a 22-residue N-terminal signal peptide and a 23-residue C-terminal hydrophobic peptide yields the mature 208-amino-acid PrP^C polypeptide (residues 23–230, molecular mass ~33–35 kDa), which is tethered to the outer leaflet of the plasma membrane—particularly at pre- and postsynaptic neuron terminals—via a C-terminal glycosylphosphatidylinositol (GPI) anchor at Ser230.

Nuclear magnetic resonance (NMR) spectroscopy revealed by Kurt Wüthrich and colleagues demonstrates that native PrP^C comprises two structurally distinct regions:

• An intrinsically disordered, flexible N-terminal tail (residues 23–120) containing five octapeptide repeats (PHGGGWGQ) that coordinate divalent copper (Cu²⁺) and zinc (Zn²⁺) ions.
• A folded globular C-terminal domain (residues 121–230) stabilized by a single disulfide bond (Cys179–Cys214) and up to two N-linked complex glycans (at Asn181 and Asn197). In this native state, PrP^C is rich in α-helices (~42% of residues, comprising three α-helices: α1, α2, and α3) and contains minimal β-sheet structure (~3%, two short antiparallel strands β1 and β2). Native PrP^C is monomeric, soluble in non-ionic detergents, and rapidly degraded by proteinase K (PK).

Conformational Refolding into Cross-β Amyloid PrP^Sc

Crucially, PrP^C and PrP^Sc share an identical primary amino acid sequence and identical covalent post-translational modifications; their divergence is strictly conformational. During conversion to PrP^Sc, the flexible N-terminal domain and α-helices α1/α2 undergo a refolding transition into an intermolecular parallel in-register intermolecular β-sheet (PIRIBS) or β-solenoid amyloid architecture. Fourier-transform infrared (FTIR) and cryo-electron microscopy (cryo-EM) studies show that PrP^Sc exhibits ~43% β-sheet content and reduced α-helicity (~30% or less).

Tight steric zipper packing of hydrophobic side chains within the cross-β core (where β-strands run perpendicular to the fibril axis with a characteristic 4.7–4.8 Å X-ray diffraction spacing) renders PrP^Sc insoluble in detergents and resistant to proteolytic cleavage. Limited digestion of PrP^Sc with proteinase K cleaves only the exposed N-terminal residues 23–89, leaving an infectious, protease-resistant core of ~142 amino acids (residues 90–230) with an apparent molecular mass of 27 to 30 kDa, designated PrP 27–30.

Nucleated Polymerization and Fragmentation Kinetics

Although PrP^Sc is thermodynamically more stable than monomeric PrP^C in an aggregated state, a high activation energy barrier (ΔG^‡) prevents spontaneous conversion of PrP^C in healthy individuals. Prion replication proceeds via a nucleated polymerization mechanism (supported by kinetic modeling of in vitro Protein Misfolding Cyclic Amplification [PMCA] and Real-Time Quaking-Induced Conversion [RT-QuIC]):

1. Lag (Nucleation) Phase: Monomeric PrP^C exists in rapid, unfavorable equilibrium with an unfolded or partially structured intermediate (PrP*). Spontaneous assembly of an oligomeric nucleus (n ≥ 6–10 monomers) is slow and rate-limiting, accounting for the multi-year or multi-decade incubation period of prion diseases. Introduction of exogenous, pre-formed PrP^Sc seeds bypasses this nucleation barrier.
2. Elongation Phase: Native PrP^C monomers bind to the exposed templating ends of a PrP^Sc oligomer and undergo induced conformational conversion into the cross-β state, extending the amyloid fibril at a rate proportional to the concentration of free fibril ends.
3. Fragmentation Phase: Mechanical shear or cellular disaggregase activity (such as the Hsp104 chaperone protein in yeast prions) severs elongated fibrils into shorter oligomers, multiplying the number of active templating ends. This coupled elongation-fragmentation cycle drives autocatalytic, exponential amplification of PrP^Sc title following N(t) = N₀ exp(k_eff t), where the effective growth rate k_eff scales with the square root of the product of the elongation and fragmentation rate constants.

Prion Strains and the Species Barrier

A longstanding challenge to the protein-only hypothesis was the existence of distinct prion strains—isolates that, when inoculated into genetically identical inbred mice, produce reproducible differences in incubation time, neuropathological lesion profiles, and PrP 27–30 glycoform ratios (proportions of di-, mono-, and unglycosylated PrP). High-resolution cryo-EM demonstrates that strain-specific properties are enciphered within distinct three-dimensional polymorphs (alternative β-arch folds and packing angles) of the PrP^Sc amyloid core. Similarly, the species barrier—the inefficiency of transmitting prions from one mammal (such as hamster or sheep) to another (such as mouse or human)—reflects the sequence and conformational compatibility between the incoming donor PrP^Sc template and the recipient host PrP^C substrate.

Resistance to Ionizing Radiation and Standard Sterilization

Early radiobiological target-theory experiments by Tikvah Alper (1967) demonstrated that the scrapie agent is insensitive to 254 nm UV radiation and ionizing electron-beam radiation at doses that destroy viral and bacterial genomes, indicating a target molecular weight (<150 kDa) too small to contain a viral nucleic acid. Furthermore, prions withstand boiling, nucleases (DNase, RNase), psoralens, alcohols, formalin/glutaraldehyde fixation (which crosslinks and further stabilizes PrP^Sc!), and standard medical steam autoclaving (121 °C for 20 minutes). Validated surgical instrument decontamination requires immersion in 1 M sodium hydroxide (NaOH) or 20,000 ppm available chlorine (sodium hypochlorite) for 1 hour, followed by porous-load steam autoclaving at 134 °C for 18–60 minutes.

Sporadic, Genetic, and Acquired Human TSEs

Human transmissible spongiform encephalopathies are unique in medicine because they manifest through three distinct etiologies—sporadic, hereditary (autosomal dominant), and acquired by infection:

• Sporadic Creutzfeldt–Jakob Disease (sCJD): Accounting for ~85% of human prion cases (annual incidence ~1–2 per million population worldwide, peak onset age 60–70 years), sCJD arises from a rare stochastic misfolding of endogenous PrP^C or a somatic PRNP mutation. Patients develop rapidly progressive dementia, myoclonus, cerebellar ataxia, and periodic sharp wave complexes on electroencephalography (EEG), progressing to akinetic mutism and death within 4–12 months.
• Genetic (Familial) Prion Diseases (~10–15% of cases): Over 50 pathogenic autosomal dominant mutations in PRNP lower the free-energy barrier for spontaneous PrP^C-to-PrP^Sc conversion. These include familial CJD (most commonly the E200K mutation), Gerstmann–Sträussler–Scheinker syndrome (GSS) (characterized by multicentric cerebellar amyloid plaques, often linked to P102L), and Fatal Familial Insomnia (FFI) (selective thalamic degeneration with untreatable insomnia and dysautonomia). Remarkably, the D178N mutation produces FFI when paired in cis with methionine at polymorphic codon 129 (D178N-129M), but produces familial CJD when paired with valine (D178N-129V).
• Acquired Prion Diseases (<1–5% of cases): Include iatrogenic CJD (transmitted via cadaveric human pituitary growth hormone, dura mater grafts, or contaminated neurosurgical electrodes), variant CJD (vCJD) (resulting from dietary exposure to bovine spongiform encephalopathy [BSE] prions during the UK cattle outbreak of the 1980s–1990s), and kuru. Investigated by D. Carleton Gajdusek among the Fore people of Papua New Guinea, kuru was transmitted through ritual endocannibalism at mortuary feasts. Population genetics of the Fore revealed strong balancing selection and heterozygote advantage at codon 129 of PRNP (which encodes either Methionine [M] or Valine [V]): while Met/Met (MM) and Val/Val (VV) homozygotes were highly susceptible to kuru and vCJD, M129V heterozygotes (and carries of the newly evolved G127V allele) were protected because heterologous PrP^C monomers inhibit homotypic PrP^Sc fibril elongation.

Animal Epizootics and Functional Fungal Prions

In non-human mammals, major TSEs include scrapie in sheep and goats, BSE in cattle (driven by recycling meat-and-bone meal in cattle feed), and chronic wasting disease (CWD) in North American and Eurasian cervids (deer, elk, moose). Unlike sCJD or BSE, CWD prions are shed abundantly in saliva, urine, and feces and bind avidly to montmorillonite clay minerals in soil, driving horizontal environmental transmission across wild herds. Beyond pathology, non-toxic functional prions operate as epigenetic cytoplasmic inheritance elements in fungi—such as the yeast Saccharomyces cerevisiae translation termination factor Sup35 ([PSI⁺]) and nitrogen regulator Ure2p ([URE3])—and play physiological roles in long-term synaptic memory maintenance via CPEB (cytoplasmic polyadenylation element-binding protein) oligomers in Aplysia and mammals.

Why does the immune system fail to mount an antibody or T-cell response during prion infection?

Because PrP^Sc has the identical primary amino acid sequence and covalent glycosylation pattern as the host's own ubiquitous cellular prion protein (PrP^C), developing B and T lymphocytes recognize PrP epitopes as "self" during thymic and bone-marrow central tolerance maturation. Consequently, prion infection evokes neither interferon production, neutralizing antibodies, nor inflammatory leukocyte infiltration into the brain parenchyma.

How does the Real-Time Quaking-Induced Conversion (RT-QuIC) assay diagnose CJD before death?

RT-QuIC mixes a patient's cerebrospinal fluid (CSF) or nasal brushings with a large excess of recombinant bacterial PrP^C substrate and the amyloid-binding fluorescent dye Thioflavin T (ThT) inside multi-well plates subjected to intermittent mechanical shaking. Femtogram quantities of PrP^Sc in the patient sample template the conversion of recombinant PrP^C into β-sheet fibrils; shaking fragments these fibrils to amplify templating ends exponentially (N(t) = N₀ exp(k_eff t)), generating a ThT fluorescence signal with >95% diagnostic sensitivity and >99% specificity for sporadic CJD.

Why do surgical instruments exposed to CJD brain tissue require 1 M NaOH and 134 °C autoclaving?

Standard hospital autoclaving (121 °C for 20 min) and aldehyde fixatives (formalin, glutaraldehyde) denature globular viral and bacterial proteins by unfolding α-helices or cross-linking amine groups. Because PrP^Sc is already in an aggregated, dehydrated cross-β steric-zipper state, heat alone only partially reduces infectivity and aldehydes cross-link the fibrils into even more stable complexes. Hydrolysis of the polypeptide backbone and beta-sheet hydrogen-bond network requires strong alkali (1 M NaOH) or oxidative cleavage (20,000 ppm NaOCl) combined with extended 134 °C steam sterilization.

1. Prusiner, S. B. (1982). "Novel proteinaceous infectious particles cause scrapie." Science, 216(4552), 136–144. https://doi.org/10.1126/science.6801762
2. Prusiner, S. B. (1998). "Prions." Proceedings of the National Academy of Sciences, 95(23), 13363–13383. https://doi.org/10.1073/pnas.95.23.13363
3. Collinge, J. (2001). "Prion diseases of humans and animals: Their causes and molecular basis." Annual Review of Neuroscience, 24, 519–550. https://doi.org/10.1146/annurev.neuro.24.1.519
4. Kraus, A., Groveman, B. R., & Caughey, B. (2013). "Prions and the potential transmissibility of protein misfolding diseases." Annual Review of Microbiology, 67, 543–564. https://doi.org/10.1146/annurev-micro-092412-155735